Targeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to date
about
High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cellsCondition medium of HepG-2 cells induces the transdifferentiation of human umbilical cord mesenchymal stem cells into cancerous mesenchymal stem cells.Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets.
P2860
Targeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to date
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeting chronic lymphocytic ...... ro and clinical trials to date
@ast
Targeting chronic lymphocytic ...... ro and clinical trials to date
@en
Targeting chronic lymphocytic ...... ro and clinical trials to date
@nl
type
label
Targeting chronic lymphocytic ...... ro and clinical trials to date
@ast
Targeting chronic lymphocytic ...... ro and clinical trials to date
@en
Targeting chronic lymphocytic ...... ro and clinical trials to date
@nl
prefLabel
Targeting chronic lymphocytic ...... ro and clinical trials to date
@ast
Targeting chronic lymphocytic ...... ro and clinical trials to date
@en
Targeting chronic lymphocytic ...... ro and clinical trials to date
@nl
P2860
P356
P1476
Targeting chronic lymphocytic ...... ro and clinical trials to date
@en
P2093
Kyle Crassini
Stephen P Mulligan
P2860
P304
P356
10.12998/WJCC.V3.I8.694
P407
P50
P577
2015-08-01T00:00:00Z